Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BX vs GSK✓SelectedUSD · GSKBX vs GSK performance historyLatest closeAs of-4.47%11/20
Stock and ETF performance explorer

BX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+14.6%
GSK return
+53.4%
Excess return
-38.8%
Maximum drawdown
-46.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.5%-0.1%-4.3%-4.5%
7D-7.8%-5.3%-2.5%-7.1%
30D+2.1%-3.7%+5.7%+2.7%
3M-20.9%-7.3%-13.6%-20.1%
6M-3.3%-4.2%+1.0%-2.7%
YTD-25.2%+0.9%-26.0%-24.9%
1Y-16.7%+7.3%-23.9%-16.7%
3Y+14.6%+52.7%-38.2%+15.2%
All+14.6%+53.4%-38.8%+15.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling